To view on your mobile phone, please click here.

Click HERE to read on your mobile device
To view this email online, please click here.
Sourcing and Management by Pharmaceutical Technology
Visit pharmtech.com
About PTSM and Subscribe
Archives
Advertise
Contact Editorial

July 2010 Volume 6 Issue 7

Welcome to the July 2010 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, a new plan by the US government to improve intellectual property protection and secure the pharmaceutical supply chain. Plus, developments of the bio/pharmaceutical industry in corporate social responsibility and sustainability.

Supply Chain
US Outlines Plan for IP Protection and Securing the Pharmaceutical Supply Chain
Patricia Van Arnum, editor of Sourcing and Management and senior editor of Pharmaceutical Technology
The US government outlines its strategy against counterfeiting and intellectual-property infringement, including ways to better secure the pharmaceutical supply chain.
More...

Outsourcing
EU Debt Crisis Adds Uncertainty
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology.
The sovereign debt crisis in the EU could greatly change the landscape for contract services.
More...

Global Feature
CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and other public and private concerns. This month, we feature articles on patient capital or venture capital used to finance social enterprises, a green-assessment tool for formulated products, and a roundup of CSR and sustainability news.

<< more on financing social enterprises, the green-assessment tool, and a CSR roundup. >>



Sourcing and Management’s Community of Experts

The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates, and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
More...


Expansion of Vetter Development Service (VDS)
The North American market is critical to Vetter’s strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago. The facility, which focuses on preclinical to phase II clinical batch projects, is an expansion of Vetter Development Service. With significant progress already having been made, the facility is scheduled to be operational by beginning of the fourth quarter 2010.

Listen Now...
 
 
FindPharma
Search

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar
Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Advertising Contact:
Mike Tracey

Editorial Contact:
Patricia Van Arnum, Editor